HLA-C and neoplasm: Extending the knowledge of the repertoire of MHC-bound tumor-derived peptides by purifying and characterizing the tumor-associated peptidome and choosing the most appropriate cocktail of peptides to prepare anti-tumor vaccines has been shown recently to be a very promising approach for the construction of suitable multi-peptide vaccine in human renal cancer (41).